Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT

Clinical trial NCT05290545 · COMPLETED

Trial details

NCT number: NCT05290545
Sponsor: Nanfang Hospital, Southern Medical University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hematological Malignancies Hematopoietic Stem Cell Transplantation

Start date: 2022-02-15
Primary completion: 2023-01-02
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.